NO20021430L - Fremgangsmåte for terapeutisk forvaltning av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte ogegglederobstruksjon - Google Patents

Fremgangsmåte for terapeutisk forvaltning av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte ogegglederobstruksjon

Info

Publication number
NO20021430L
NO20021430L NO20021430A NO20021430A NO20021430L NO 20021430 L NO20021430 L NO 20021430L NO 20021430 A NO20021430 A NO 20021430A NO 20021430 A NO20021430 A NO 20021430A NO 20021430 L NO20021430 L NO 20021430L
Authority
NO
Norway
Prior art keywords
ovary
obstruction
procedure
pelvic pain
chronic pelvic
Prior art date
Application number
NO20021430A
Other languages
English (en)
Other versions
NO331198B1 (no
NO20021430D0 (no
Inventor
Juergen Engel
Hilde Riethmueller-Winzen
Ricardo Felberbaum
Klaus Diedrich
Wolfgang KUEPKER
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of NO20021430D0 publication Critical patent/NO20021430D0/no
Publication of NO20021430L publication Critical patent/NO20021430L/no
Publication of NO331198B1 publication Critical patent/NO331198B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20021430A 1999-09-23 2002-03-21 Anvendelse av LHRH-antagonist for fremstilling av et medikament til terapeutisk styring av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte og egglederobstruksjon NO331198B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15547899P 1999-09-23 1999-09-23
PCT/EP2000/009212 WO2001021194A2 (en) 1999-09-23 2000-09-20 Method for the therapeutic management of endometriosis and fallopian tube obstruction

Publications (3)

Publication Number Publication Date
NO20021430D0 NO20021430D0 (no) 2002-03-21
NO20021430L true NO20021430L (no) 2002-05-07
NO331198B1 NO331198B1 (no) 2011-10-31

Family

ID=22555601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021430A NO331198B1 (no) 1999-09-23 2002-03-21 Anvendelse av LHRH-antagonist for fremstilling av et medikament til terapeutisk styring av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte og egglederobstruksjon

Country Status (22)

Country Link
EP (1) EP1214086A2 (no)
JP (2) JP2003509467A (no)
KR (1) KR100772852B1 (no)
CN (2) CN101045155A (no)
AU (1) AU769482B2 (no)
BG (1) BG66128B1 (no)
BR (1) BR0014198A (no)
CA (1) CA2383510A1 (no)
HK (1) HK1049117A1 (no)
HU (1) HUP0202741A3 (no)
IL (1) IL148185A0 (no)
MX (1) MXPA02002436A (no)
NO (1) NO331198B1 (no)
NZ (1) NZ534836A (no)
PL (1) PL201898B1 (no)
RU (1) RU2255759C2 (no)
SK (1) SK3752002A3 (no)
TR (1) TR200200738T2 (no)
TW (1) TWI267373B (no)
UA (1) UA73956C2 (no)
WO (1) WO2001021194A2 (no)
ZA (1) ZA200201374B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157628A1 (de) * 2001-11-26 2003-06-12 Zentaris Ag Injektionslösung eines LHRH-Antagonisten
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
KR101863136B1 (ko) 2008-01-24 2018-05-31 에스퍼란스 파마슈티컬스, 인코포레이티드 용해 도메인 융합 구성물 및 이를 제조하고 사용하는 방법
EP2379099A1 (en) * 2009-01-22 2011-10-26 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
IL238323B2 (en) 2012-10-30 2023-11-01 Esperance Pharmaceuticals Inc Antibody/drug conjugates and methods of use
IL241595B2 (en) 2013-03-15 2025-10-01 Abbvie Inc Composition for use in methods of treating heavy menstrual bleeding associated with uterine fibroids
CN111698992A (zh) 2017-08-18 2020-09-22 艾伯维公司 用于治疗子宫内膜异位症、子宫肌瘤、多囊卵巢综合症或子宫腺肌症的药物配制物
TW201912157A (zh) 2017-08-18 2019-04-01 美商艾伯維有限公司 治療子宮內膜異位症、子宮纖維瘤、多囊性卵巢症候群及子宮腺肌症之固體醫藥調配物
AU2018419533A1 (en) 2018-04-19 2020-11-12 Abbvie Inc. Methods of treating heavy menstrual bleeding
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
EE03515B1 (et) * 1994-07-22 2001-10-15 The Medical College Of Hampton Roads GnRH antagonist kasutamiseks gonadaalsteroid-sõltuva seisundi ravis
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
RU2108583C1 (ru) * 1996-07-29 1998-04-10 Николай Владимирович Рымашевский Способ определения показаний к проведению гормонотерапии у больных генитальным эндометриозом
CN1228708A (zh) * 1996-09-04 1999-09-15 有限会社多特 经口给药用含肽药物组合物
AU729752B2 (en) * 1997-06-05 2001-02-08 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
TWI267373B (en) 2006-12-01
HUP0202741A2 (hu) 2003-01-28
TR200200738T2 (tr) 2002-08-21
PL201898B1 (pl) 2009-05-29
ZA200201374B (en) 2002-10-30
UA73956C2 (en) 2005-10-17
HK1049117A1 (zh) 2003-05-02
KR100772852B1 (ko) 2007-11-02
EP1214086A2 (en) 2002-06-19
JP2003509467A (ja) 2003-03-11
PL353244A1 (en) 2003-11-03
WO2001021194A2 (en) 2001-03-29
NO331198B1 (no) 2011-10-31
BG106584A (bg) 2003-02-28
AU7779200A (en) 2001-04-24
CN1376070A (zh) 2002-10-23
CN101045155A (zh) 2007-10-03
AU769482B2 (en) 2004-01-29
IL148185A0 (en) 2002-09-12
NZ534836A (en) 2007-07-27
BR0014198A (pt) 2002-05-21
HUP0202741A3 (en) 2003-12-29
MXPA02002436A (es) 2003-02-12
SK3752002A3 (en) 2003-06-03
NO20021430D0 (no) 2002-03-21
BG66128B1 (bg) 2011-06-30
KR20020035879A (ko) 2002-05-15
RU2255759C2 (ru) 2005-07-10
CA2383510A1 (en) 2001-03-29
WO2001021194A3 (en) 2002-03-14
JP2012051920A (ja) 2012-03-15

Similar Documents

Publication Publication Date Title
EE200100603A (et) Inimese refraktaarsete kasvajate ravi epidermaalse kasvufaktori retseptori antagonistidega
AU2002351397A8 (en) Systems and methods using vasoconstriction for improved thermal treatment of tissues
IL148496A0 (en) Therapeutic quinazoline derivatives
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
AU2001280440A1 (en) Treatment of human herpesviruses using hyperthermia
NO20042208L (no) Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter
DE59906118D1 (de) Beschichtete medizinische geräte und implantate
NO20021430L (no) Fremgangsmåte for terapeutisk forvaltning av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte ogegglederobstruksjon
NO20021094D0 (no) Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
HU0002509D0 (en) Combination therapy for treatment of migraine
SI1173179T1 (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent major depressive disorders
IL130171A0 (en) Therapeutic use of melatonin
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
NO20020784L (no) Medikament for behandling av brudd
HUP0105310A3 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
HU0002508D0 (en) Combination therapy for treatment of migraine
HU0001891D0 (en) Medicament for the treatment of migraine
NO20014476L (no) Behandling av hiatial hernia
ES1043751Y (es) Tabla vibradora de efectos terapeuticos.
SI1303306T1 (sl) Kombinacijska terapija z epoksi-steroidnim aldosteronskim antagonistom in betaadrenergicnim antagonistom za zdravljenje kongestivne srcne odpovedi
IT1311582B1 (it) Ortesi ortopedica per il trattamento di epicondiliti.
DK199900219U3 (da) Kiropraktisk behandlings- og sidelejebehandlingsbord
IL126778A0 (en) Administration of histamine for therapeutic purposes

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees